A detailed history of Stonepine Capital Management, LLC transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 100,000 shares of TSVT stock, worth $299,000. This represents 0.3% of its overall portfolio holdings.

Number of Shares
100,000
Previous 100,000 -0.0%
Holding current value
$299,000
Previous $385 Million 22.6%
% of portfolio
0.3%
Previous 0.35%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.6 - $5.79 $360,000 - $579,000
100,000 New
100,000 $385 Million

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.